MYCELX Technologies Corporation (AIM: MYX)
London
· Delayed Price · Currency is GBP · Price in GBX
37.50
0.00 (0.00%)
Nov 28, 2024, 8:26 AM GMT+1
MYCELX Technologies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 8.84 | 10.91 | 10.03 | 8.48 | 7.1 | 11.91 | Upgrade
|
Revenue Growth (YoY) | -25.69% | 8.79% | 18.26% | 19.34% | -40.34% | -55.82% | Upgrade
|
Cost of Revenue | 6.48 | 7.02 | 5.58 | 5.2 | 5.51 | 5.82 | Upgrade
|
Gross Profit | 2.36 | 3.89 | 4.44 | 3.28 | 1.59 | 6.09 | Upgrade
|
Selling, General & Admin | 6.03 | 6.74 | 7.59 | 6.94 | 7.27 | 7.75 | Upgrade
|
Research & Development | 0.25 | 0.25 | 0.22 | 0.22 | 0.06 | 0.35 | Upgrade
|
Operating Expenses | 6.5 | 7.22 | 8.02 | 7.37 | 7.65 | 8.49 | Upgrade
|
Operating Income | -4.14 | -3.33 | -3.58 | -4.09 | -6.05 | -2.41 | Upgrade
|
Interest Expense | -0.01 | -0.01 | - | -0.02 | -0.12 | -0.08 | Upgrade
|
EBT Excluding Unusual Items | -4.16 | -3.34 | -3.58 | -4.12 | -6.17 | -2.49 | Upgrade
|
Gain (Loss) on Sale of Assets | 0.84 | - | 0 | 2.58 | - | -0.01 | Upgrade
|
Other Unusual Items | - | - | - | 0.4 | 0.4 | - | Upgrade
|
Pretax Income | -3.32 | -3.34 | -3.57 | -1.13 | -5.77 | -2.5 | Upgrade
|
Income Tax Expense | 0.24 | 0.37 | 0.42 | 0.3 | 0.33 | 0.46 | Upgrade
|
Net Income | -3.56 | -3.71 | -3.99 | -1.43 | -6.09 | -2.96 | Upgrade
|
Net Income to Common | -3.56 | -3.71 | -3.99 | -1.43 | -6.09 | -2.96 | Upgrade
|
Shares Outstanding (Basic) | 23 | 23 | 22 | 19 | 19 | 19 | Upgrade
|
Shares Outstanding (Diluted) | 23 | 23 | 22 | 19 | 19 | 19 | Upgrade
|
Shares Change (YoY) | -0.04% | 3.46% | 14.25% | - | 0.68% | -3.45% | Upgrade
|
EPS (Basic) | -0.15 | -0.16 | -0.18 | -0.07 | -0.31 | -0.15 | Upgrade
|
EPS (Diluted) | -0.15 | -0.16 | -0.18 | -0.07 | -0.31 | -0.15 | Upgrade
|
Free Cash Flow | -1.59 | -1.21 | -3.5 | -3.75 | -1.61 | -2.73 | Upgrade
|
Free Cash Flow Per Share | -0.07 | -0.05 | -0.16 | -0.19 | -0.08 | -0.14 | Upgrade
|
Gross Margin | 26.69% | 35.67% | 44.30% | 38.63% | 22.41% | 51.11% | Upgrade
|
Operating Margin | -46.88% | -30.55% | -35.66% | -48.27% | -85.21% | -20.20% | Upgrade
|
Profit Margin | -40.30% | -33.98% | -39.81% | -16.81% | -85.78% | -24.85% | Upgrade
|
Free Cash Flow Margin | -17.93% | -11.05% | -34.91% | -44.27% | -22.64% | -22.90% | Upgrade
|
EBITDA | -3.48 | -2.46 | -2.48 | -2.97 | -4.63 | -1.14 | Upgrade
|
EBITDA Margin | -39.39% | -22.59% | -24.78% | -35.01% | -65.12% | -9.55% | Upgrade
|
D&A For EBITDA | 0.66 | 0.87 | 1.09 | 1.12 | 1.43 | 1.27 | Upgrade
|
EBIT | -4.14 | -3.33 | -3.58 | -4.09 | -6.05 | -2.41 | Upgrade
|
EBIT Margin | -46.88% | -30.55% | -35.66% | -48.27% | -85.21% | -20.20% | Upgrade
|
Advertising Expenses | - | - | - | 0.01 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.